- Home
- MURA vs CNTX Comparison
MURA vs CNTX Comparison
Compare MURA & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MURA
- CNTX
- Stock Information
- Founded
- MURA 2013
- CNTX 2015
- Country
- MURA Ireland
- CNTX United States
- Employees
- MURA N/A
- CNTX N/A
- Industry
- MURA
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- MURA
- CNTX Health Care
- Exchange
- MURA Nasdaq
- CNTX Nasdaq
- Market Cap
- MURA N/A
- CNTX 60.7M
- IPO Year
- MURA N/A
- CNTX 2021
- Fundamental
- Price
- MURA $1.26
- CNTX $0.62
- Analyst Decision
- MURA Strong Buy
- CNTX Strong Buy
- Analyst Count
- MURA 5
- CNTX 5
- Target Price
- MURA $13.00
- CNTX $6.50
- AVG Volume (30 Days)
- MURA 421.2K
- CNTX 73.1K
- Earning Date
- MURA 03-11-2025
- CNTX 03-20-2025
- Dividend Yield
- MURA N/A
- CNTX N/A
- EPS Growth
- MURA N/A
- CNTX N/A
- EPS
- MURA N/A
- CNTX N/A
- Revenue
- MURA N/A
- CNTX N/A
- Revenue This Year
- MURA $79.64
- CNTX N/A
- Revenue Next Year
- MURA N/A
- CNTX N/A
- P/E Ratio
- MURA N/A
- CNTX N/A
- Revenue Growth
- MURA N/A
- CNTX N/A
- 52 Week Low
- MURA $1.11
- CNTX $0.60
- 52 Week High
- MURA $5.02
- CNTX $2.75
- Technical
- Relative Strength Index (RSI)
- MURA 19.38
- CNTX 37.10
- Support Level
- MURA $3.77
- CNTX $0.64
- Resistance Level
- MURA $4.35
- CNTX $0.99
- Average True Range (ATR)
- MURA 0.26
- CNTX 0.09
- MACD
- MURA -0.30
- CNTX -0.01
- Stochastic Oscillator
- MURA 4.92
- CNTX 7.69
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.